News | March 24, 2026
Bayer wins world-first nod in Japan for low-dose MRI contrast agent
Call it a major breakthrough for diagnostic imaging
Call it a major breakthrough for diagnostic imaging
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
Pharmaceutical manufacturer Wanbury Limited (WL) has strengthened its position in the Brazilian market after securing regulatory approval for Sertraline Form II from Brazil’s health regulator, ANVISA
The FDA classified LifeVac as a Class II medical device
The approval comes after a systematic review of published literature
The FDA decision was based on results from the pivotal POETYK PsA-1 and POETYK PsA-2 Phase 3 trials
DiaMedica said it plans to launch the trial later in 2026
This new treatment option can redefine how we approach RRMM treatment by giving healthcare providers a regimen with improvement in PFS and OS and a well-characterized safety profile
Subscribe To Our Newsletter & Stay Updated
